Reaction

Anaemia Macrocytic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,091 reports · 80 co-occurring drugs

As of the last recalculation, Anaemia Macrocytic appears in 2,091 FAERS reports alongside 80 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 83.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Zidovudine	107	83.9	84.6
Lamivudine	79	26.4	26.5
Esomeprazole Magnesium Capsule, Delayed Release	25	17.3	17.4
Esomeprazole Magnesium Delayed Release Capsules	25	17.3	17.4
Esomeprazole Magnesium Dihydrate	25	17.3	17.3
Lamivudine Oral	39	15.6	15.6
Esomeprazole	88	14.7	14.7
Nevirapine	13	14.4	14.4
Epoetin Alfa	17	14.4	14.4
Hydroxyurea	30	14.3	14.3
Valganciclovir Hydrochloride Powder,	16	13.2	13.2
Telmisartan	23	13.0	13.0
Tenofovir Disoproxil Fumarate Tablets	11	12.7	12.8
Linagliptin	23	12.7	12.7
Abacavir Sulfate	11	11.3	11.3
Atovaquone	9	11.2	11.2
Fondaparinux Sodium	9	11.1	11.1
Lopinavir And Ritonavir	15	11.1	11.1
Ritonavir	32	11.1	11.1
Febuxostat Tablets 40 Mg	11	10.8	10.8
Febuxostat Tablets 80 Mg	11	10.8	10.8
Efavirenz	12	10.8	10.8
Daspone	10	10.3	10.3
Dapsone Gel, 5%	10	10.3	10.3
Phenytoin	21	10.1	10.1
Sulfamethoxazole And Trimethoprim	78	9.5	9.5
Memantine	13	9.5	9.5
Memantine Hydrochloride	13	9.5	9.5
Dapsone	10	9.4	9.4
Sotalol Hydrochloride	15	9.0	9.0
Febuxostat	15	9.0	9.0
Ritonavir 100 Mg	13	8.7	8.7
Valganciclovir	16	8.5	8.5
Valganciclovir Hydrochloride	16	8.5	8.5
Acetylcysteine	8	8.5	8.5
Bisoprolol Fumarate	105	8.0	8.1
Darunavir	12	7.9	7.9
Raltegravir	13	7.9	7.9
Ramipril	93	7.8	7.8
Ivacaftor	6	7.5	7.5
Mercaptopurine	13	7.5	7.5
Allopurinol	110	7.3	7.3
Tenofovir Disoproxil Fumarate	24	7.3	7.3
Divalproex Sodium	33	7.2	7.2
Eplerenone	9	7.0	7.0
Valproic Acid	22	7.0	7.0
Pemetrexed	15	7.0	7.0
Atazanavir	10	7.0	7.0
Nebivolol	11	6.9	6.9
Imatinib	12	6.8	6.8
Olaparib	14	6.7	6.7
Romiplostim	10	6.6	6.6
Palbociclib	56	6.0	6.0
Pemetrexed Disodium	22	5.8	5.8
Imatinib Mesylate	16	5.7	5.7
Norepinephrine	6	5.6	5.6
Trifluridine And Tipiracil	6	5.6	5.6
Letrozole Tablets	26	5.4	5.4
Baricitinib	5	5.2	5.2
Dorzolamide Hydrochloride And Timolol Maleate	4	5.0	5.0
Timolol Maleate	5	5.0	5.0
Niraparib	11	5.0	5.0
Dutasteride	4	4.9	4.9
Rivastigmine	9	4.8	4.8
Methoxy Polyethylene Glycol-Epoetin Beta	5	4.5	4.5
Clobazam	11	4.5	4.5
Paricalcitol	6	4.2	4.2
Bendamustine Hydrochloride	5	4.2	4.2
Sofosbuvir	8	4.0	4.0
Carfilzomib	11	3.9	3.9
Obinutuzumab	6	3.6	3.6
Bortezomib	32	3.6	3.6
Ribavirin	23	3.6	3.6
Acalabrutinib	4	3.3	3.3
Erlotinib	3	3.1	3.1
Peginterferon Alfa-2A	16	3.0	3.0
Abemaciclib	5	2.5	2.5
Avapritinib	3	2.5	2.5
Vigabatrin	3	2.1	2.1
Salicylic Acid	8	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.